Bayard, P.A. is serving as lead counsel to ABT Molecular Imaging, Inc. (“ABT”) in its Chapter 11 case, filed on June 13, 2018 in the Bankruptcy Court for the District Court of Delaware.  ABT is a medical imaging company, headquartered in Knoxville, Tennessee.  ABT designs, manufactures and distributes the world’s first and only small-footprint Biomarker Generator for Fludeoxyglucose, the imaging agent used in positron emission tomography (“PET”).  Through its Chapter 11 case, ABT will solicit going concern bids for its business or, alternatively, reorganize through a chapter 11 plan.

Bayard attorneys Justin R. Alberto, Erin R. Fay, Daniel N. Brogan, and Gregory J. Flasser are involved in the matter.